Marie-Chantal Fortin

Author

Université de Montréal ORCID

Also Known As

Fortin, M.C., Fortin, Marie-Chantal, M Fortin, M. FORTIN, M. Fortin, M.-C. Fortin, Marie-Chantal Fortin

Publications

467

Citations

H-Index

Concepts

All Affiliations

Université de Montréal Centre Hospitalier de l’Université de Montréal Université Laval Hôpital Notre-Dame Toronto Metropolitan University

About

Marie-Chantal Fortin is an author at Université de Montréal specializing in medicine, drug discovery, and neuropharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	185
2	Engineering	1	1	31
3	Health Sciences	1	1	20
4	Natural Sciences	1	1	34
5	Biochemistry	1	1	34

Marie-Chantal Fortin

Publications

375

Citations

H-Index

Page 1

	Year	Citations
Increased Risk of Thrombotic Microangiopathy in Patients Receiving a Cyclosporin–Sirolimus Combination Marie-Chantal Fortin, Marc‐André Raymond, François Madore, American Journal of Transplantation ThrombosisVenous ThrombosisVasculitisPathologyCyclosporin–sirolimus Combination	2004	115
1-Alkyl-1,2,5,6-tetrahydropyridine-3-carboxaldehyde-O-alkyl-oximes: a new class of potent orally active muscarinic agonists related to arecoline E. TOJA, C Bonetti, A Butti, European Journal of Medicinal Chemistry Medicinal ChemistryBiochemistryMedicineActive Muscarinic AgonistsNatural Sciences	1991	34
Finite element simulation of dip coating, II: Non‐Newtonian fluids Philippe A. Tanguy, Marie-Chantal Fortin, L. Choplin International Journal for Numerical Methods in Fluids EngineeringFinite Element SimulationFluid MechanicsMechanical EngineeringComputational Mechanics	1984	31
The measurement of sexual orientation: Historical background and current practices Dominic Beaulieu‐Prévost, Marie-Chantal Fortin Sexologies	2014	29
Web-Based Tailored Intervention to Support Optimal Medication Adherence Among Kidney Transplant Recipients: Pilot Parallel-Group Randomized Controlled Trial José Côté, Marie-Chantal Fortin, Patricia Auger, JMIR Formative Research	2018	29
The use of personalized medicine for patient selection for renal transplantation: Physicians' views on the clinical and ethical implications Marianne Dion-Labrie, Marie-Chantal Fortin, Marie‐Josée Hébert, BMC Medical Ethics	2010	23
The dopamine D2 agonists RU 24213 and RU 24926 are also KAPPA-opioid receptor antagonists Marie-Chantal Fortin, M. Degryse, Florence Petit, Neuropharmacology Molecular PharmacologyFunctional SelectivityAddictionMedicineOpioid Use Disorder	1991	20
What does patient engagement mean for Canadian National Transplant Research Program Researchers? Julie Allard, Fabián Ballesteros, Samantha J. Anthony, Research Involvement and Engagement	2018	18
1-substituted-1,2,5,6-tetrahydropyridine-3-carboxaldehyde-O-alkyloximes as novel orally active and long-lasting muscarinic cholinergic agonists E. TOJA, C Bonetti, A Butti, European Journal of Medicinal Chemistry MedicineMechanism Of ActionPharmacological AgentNeuropharmacologyPharmacotherapy	1992	16
Peer Mentoring as an Avenue to Explore in Kidney Transplantation: Kidney Transplant Recipients’ Perspectives on Peer Mentoring Marie‐Pascale Pomey, Fabián Ballesteros Gallego, Alya Affdal, Transplantation Direct	2021	15

Page 1